International Stem Cell Corporation (ISCO)

Other OTC - Other OTC Delayed Price. Currency in USD

0.1210

0.0000

(0.00%)

At close: 10:11AM EDT

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.1210
Open	0.1210
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	0.1210 - 0.1210
52 Week Range	0.0600 - 0.4000
Volume	3
Avg. Volume	1,895

Market Cap	968,531
Beta (5Y Monthly)	0.58
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0100
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ISCO

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

INTERNATIONAL STEM CELL CORPORA
Analyst Report: Thermo Fisher Scientific Inc.Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).
Rating
Fair Value
Economic Moat
26 days agoMorningstar